Anti-Tumor Necrosis Factor-α Therapy (Anti-TNF-α Therapy)


Indications


Anti-Tumor Necrosis Factor-α (Anti-TNFα) Agents


Pharmacology

Physiology of TNFα


General Adverse Effects of Anti-Tumor Necrosis Factor-α (Anti-TNFα) Therapy

Dermatologic Adverse Effects

Erythema Multiforme (see Erythema Multiforme)

Infectious Adverse Effects

Pulmonary Adverse Effects

Accelerated Progression of Rheumatoid Lung Nodules (see Rheumatoid Arthritis)

Acute Respiratory Distress Syndrome (ARDS) (see Acute Respiratory Distress Syndrome)

Granulomatous Lung Disease (see Granulomatous Lung Disease)

Interstitial Lung Disease (ILD) (see Interstitial Lung Disease)

Pulmonary Infiltrates with Eosinophilia (see Drug-Induced Pulmonary Eosinophilia)

Renal Adverse Effetcs

Acute Interstitial Nephritis (see Acute Interstitial Nephritis)

Rheumatologic Adverse Effects

Accelerated Progression of Rheumatoid Lung Nodules (see Rheumatoid Arthritis)

Drug-Induced Systemic Lupus Erythematosus (SLE) (see Systemic Lupus Erythematosus)


References